Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades.
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...
Cancer remains one of the most serious health challenges in the world. It occurs when cells in the body begin to grow uncontrollably and form tumors that can spread to other organs. Although modern ...
Head and neck cancer (HNC) represents a significant global health challenge, characterized by aggressive local invasion, frequent recurrence, and poor survival rates. Beyond its physical burden, HNC ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Pancreatic cancer is widely known as one of the most dangerous and difficult cancers to treat. Among the different types of pancreatic cancer, the most common and aggressive form is called pancreatic ...
A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...
For the first time in 30 years, there is a new FDA-approved treatment for locally advanced pancreatic cancer. Frederick Health is the first in the U.S. to bring this advancement to patients. It’s ...
New molecular insights into the link between hepatocellular carcinoma and intratumoral fibrosis could lead to better treatment strategies, report researchers from Institute of Science Tokyo. Through a ...
Jean Trebek, Lisa Swayze, Joan Vassos, Stephen Nichols, Jeff Mauro, Jonathan Frakes, Kitty Swink, Rosa Blasi and Many More Raise [...] READ MORE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results